Cancer News and Research

Latest Cancer News and Research

Pro-Pharmaceuticals announces financial results for the third quarter and first nine months of fiscal 2009

Pro-Pharmaceuticals, Inc., a developer of galectin-targeted, carbohydrate therapeutic compounds to treat cancer and fibrosis, today reported its financial results for the third quarter and first nine months of fiscal 2009. These results are included in the Company’s Quarterly Report on Form 10-Q for the three- and nine-month periods ended September 30, 2009, which has been filed with the SEC.

13 Nov 2009

In rural Kentucky, an unexpected take on the health debate

Frank Browning reports for Kaiser Health News on how the health reform debate is playing out in rural Kentucky. "From a strip-mined bluff at the edge of this famous mountain town you can see one of the most concentrated and diverse sets of medical facilities in rural America: a general hospital, a psychiatric hospital, a university-based rural health care center and clinics for primary care, cancer, urology, cardiology, addiction and ear-nose-and throat problems.

13 Nov 2009

Third quarter 2009 financial results announced by Soligenix

Soligenix, Inc., (Soligenix or the Company) (OTC Bulletin Board: SNGX), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today its financial results for the third quarter of 2009.

13 Nov 2009

Amorfix Life Sciences reports operating results for the three months ended September 30, 2009

Amorfix Life Sciences, a company focused on misfolded protein diseases, today reported its second quarter operating results and provided an update on the Company's diagnostic and therapeutic programs.

13 Nov 2009

First Edition: November 13, 2009

On this Friday the 13th, the headlines offer an array of health policy views -- from the possibility of including a Medicare payroll tax in health reform legislation to continuing analysis of the overhaul's winners and losers as well as the CDC's new estimate of the far-reach of the swine flu.

13 Nov 2009

Easy and affordable genetic test from Pathway Genomics

Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company, today announced an exclusive agreement to partner with OptumHealthSM Allies and offer the organization’s 15 million members a 20% discount on Pathway’s Health and Ancestry genetic test.

13 Nov 2009

CNS Pharmaceuticals' common shares sponsored by 886 AG on the electronic trading platform Xetra

CNS PHARMACEUTICALS AG, (C35.F) a developer and marketer of patented natural nutraceutical products is pleased to announce that the Company’s common shares is sponsored by the German Securities Trading Bank 886 AG Wertpapier Handelsbank on the electronic trading platform Xetra.

13 Nov 2009

ContextVision, SharpView, MGH and CMIV announce a collaborative study on advanced 3D image filtering

A collaborative study between ContextVision AB, SharpView AB, Massachusetts General Hospital (MGH) and the Center for Medical Image Science and Visualization (CMIV) was announced today. The study will investigate advanced 3D image filtering as a means of increasing patient throughput and improving image quality in MRI and further enabling dose reduction in CT. Researchers will compare state-of-the-art 3D techniques with 2D filters.

13 Nov 2009

Low-level physical activity has beneficial effects on materno-foetal health: Study

Contrary to more conservative customs, exercising up to the end of pregnancy has no harmful effect on the weight or size of the foetus. This is what has been indicated in a study carried out by researchers of the Universidad Polit-cnica de Madrid (Polytechnic University of Madrid), which also shows the positive relationship between the weight of sedentary mothers before pregnancy and the body size of their babies. The conclusions appear in the International Journal of Obesity.

13 Nov 2009

PAF receives additional funding support for serving patients with multiple myeloma

Patient Advocate Foundation (PAF) -- a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases -- is pleased to announce that it has received additional funding support for serving patients with multiple myeloma through its Co-Pay Relief Program (CPR).

13 Nov 2009

Pharmacyclics to present clinical updates and posters relating to PCI-24781 and PCI-32765

Pharmacyclics, Inc. today announced that posters related to PCI-24781 and PCI-32765 have been selected for presentation at the 51st Annual Meeting of the American Society of Hematology (ASH), December 5-8, 2009 in New Orleans, LA.

13 Nov 2009

Axelar AB to present data from ongoing Phase I/II clinical trial of AXL1717

Axelar AB today announced that promising data from the ongoing Phase I/II clinical trial concerning their lead anticancer product AXL1717, an insulin-like growth factor-1 (IGF-1) receptor inhibitor, will be presented next week at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, Massachusetts, USA.

13 Nov 2009

CSHL solves the structure of the zinc-bound ATD domain of the NMDA receptor NR2B subunit

A team of scientists at Cold Spring Harbor Laboratory (CSHL) reports on Thursday their success in solving the molecular structure of a key portion of a cellular receptor implicated in Alzheimer's, Parkinson's, and other serious illnesses.

13 Nov 2009

Findings on the use of Traumeel S in children with mucositis undergoing SCT presented

New research findings presented today at the Society for Integrative Oncology's (SIO) Sixth International Conference in New York show promise in assessing the efficacy and safety of complementary and alternative medicine (CAM) using traditional research methods.

13 Nov 2009

Researchers find a new way to tackle colon cancer

One difficulty with fighting cancer cells is that they are similar in many respects to the body's stem cells. By focusing on the differences, researchers at Karolinska Institutet have found a new way of tackling colon cancer. The study is presented in the prestigious journal Cell.

13 Nov 2009

Exercise during pregnancy does not harm the health of foetus

Contrary to more conservative customs, exercising up to the end of pregnancy has no harmful effect on the weight or size of the foetus. This is what has been indicated in a study carried out by researchers of the Universidad Politécnica de Madrid (Polytechnic University of Madrid), which also shows the positive relationship between the weight of sedentary mothers before pregnancy and the body size of their babies.

13 Nov 2009

CaringBridge, a solution to keep patients from feeling isolated during hospital stays

Hospitals are placing higher restrictions on their visitation policies due to the threat of H1N1. While this helps reduce exposure to the virus, it also means that patients will see less of their family and friends, increasing their feeling of isolation.

13 Nov 2009

Lipid that accumulates in brain cells drives cell death, says research

The lipid that accumulates in brain cells of individuals with an inherited enzyme disorder also drives the cell death that is a hallmark of the disease, according to new research led by St. Jude Children's Research Hospital investigators.

13 Nov 2009

Alternative proposal from HSPH to AAFP for developing web content on beverages

Leading Harvard School of Public Health (HSPH) nutrition and health researcher Walter Willett, M.D., Dr. P.H., has written a letter to the President-elect of the American Academy of Family Physicians (AAFP) offering an alternative to the organization's decision, announced in October, to accept a six-figure grant from the Coca-Cola Company to develop web content on beverages and maintaining a healthy lifestyle.

13 Nov 2009

Study: Coffee might be effective to fight against colon cancer

A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists.

13 Nov 2009

Cancer News and Research

Latest Cancer News and Research

Pro-Pharmaceuticals announces financial results for the third quarter and first nine months of fiscal 2009

In rural Kentucky, an unexpected take on the health debate

Third quarter 2009 financial results announced by Soligenix

Amorfix Life Sciences reports operating results for the three months ended September 30, 2009

First Edition: November 13, 2009

Easy and affordable genetic test from Pathway Genomics

CNS Pharmaceuticals' common shares sponsored by 886 AG on the electronic trading platform Xetra

ContextVision, SharpView, MGH and CMIV announce a collaborative study on advanced 3D image filtering

Low-level physical activity has beneficial effects on materno-foetal health: Study

PAF receives additional funding support for serving patients with multiple myeloma

Pharmacyclics to present clinical updates and posters relating to PCI-24781 and PCI-32765

Axelar AB to present data from ongoing Phase I/II clinical trial of AXL1717

CSHL solves the structure of the zinc-bound ATD domain of the NMDA receptor NR2B subunit

Findings on the use of Traumeel S in children with mucositis undergoing SCT presented

Researchers find a new way to tackle colon cancer

Exercise during pregnancy does not harm the health of foetus

CaringBridge, a solution to keep patients from feeling isolated during hospital stays

Lipid that accumulates in brain cells drives cell death, says research

Alternative proposal from HSPH to AAFP for developing web content on beverages

Study: Coffee might be effective to fight against colon cancer

Understanding the DNA Damage Response in Innate Immunity eBook

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Newsletters you may be interested in